Attie C. Jorge

Av. Vital Brasil 1500, São Paulo
Sao Paulo, SP 05503900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Controlled vs. non-controlled culture systems for SARS-CoV-2 VLP production using the baculovirus/SF9 platform.

Controlled vs. non-controlled culture systems for SARS-CoV-2 VLP production using the baculovirus/SF9 platform.

Journal: Preparative biochemistry & biotechnology

Published: May 05, 2026

Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens.

Non-clinical analysis of virus-like particles (VLP) containing SARS-CoV-2 vaccine antigens.

Journal: Vaccine

Published: June 05, 2025

Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.

Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.

Journal: Frontiers in immunology

Published: April 16, 2023

Zika virus-like particles (VLPs) produced in insect cells.

Zika virus-like particles (VLPs) produced in insect cells.

Journal: Frontiers in pharmacology

Published: March 07, 2023

Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms.

Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms.

Journal: Vaccines

Published: September 19, 2022

Anti-SARS-CoV-2 equine F (Ab')2 immunoglobulin as a possible therapy for COVID-19.

Anti-SARS-CoV-2 equine F (Ab')2 immunoglobulin as a possible therapy for COVID-19.

Journal: Scientific reports

Published: September 23, 2021

Strategies for the Production of Soluble Interferon-Alpha Consensus and Potential Application in Arboviruses and SARS-CoV-2.

Strategies for the Production of Soluble Interferon-Alpha Consensus and Potential Application in Arboviruses and SARS-CoV-2.

Journal: Life (Basel, Switzerland)

Published: April 07, 2021

A new class of antimicrobial molecules derived from kefir, effective against Pseudomonas aeruginosa and methicillin resistant Staphylococcus aureus (MRSA) strains.

A new class of antimicrobial molecules derived from kefir, effective against Pseudomonas aeruginosa and methicillin resistant Staphylococcus aureus (MRSA) strains.

Journal: Scientific reports

Published: February 18, 2020

Purification of rabies virus glycoprotein produced in Drosophila melanogaster S2 cells: An efficient immunoaffinity method.

Purification of rabies virus glycoprotein produced in Drosophila melanogaster S2 cells: An efficient immunoaffinity method.

Journal: Biotechnology progress

Published: October 28, 2019

DROSOPHILA S2 cell culture in a WAVE Bioreactor: potential for scaling up the production of the recombinant rabies virus glycoprotein.

DROSOPHILA S2 cell culture in a WAVE Bioreactor: potential for scaling up the production of the recombinant rabies virus glycoprotein.

Journal: Applied microbiology and biotechnology

Published: December 29, 2017

Expression of Viral Envelope Glycoproteins in Drosophila melanogaster S2 Cells.

Expression of Viral Envelope Glycoproteins in Drosophila melanogaster S2 Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 04, 2016

Rabies vaccine development by expression of recombinant viral glycoprotein.

Rabies vaccine development by expression of recombinant viral glycoprotein.

Journal: Archives of virology

Published: June 08, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026